Moreover, our results imply that prevention of binding of Sp1 to the ZNF132 promoter region by hypermethylation may be one of the mechanisms for reducing ZNF132 expression in ESCC. This evidence concerns the gene SP1 and esophageal squamous cell carcinoma.